Physician profile
Steven Young
NPI 1629498787
$7,095.91
in general payments reported to CMS, 2019-2025
10 companies · $6,305 in 2025
The $6,305 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.03 · 2020: $12.98 · 2021: $88.69 · 2023: $107 · 2024: $503 · 2025: $6,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,680 · Food and Beverage: $1,256 · Travel and Lodging: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,680.00 |
| Food and Beverage | $1,255.89 |
| Travel and Lodging | $979.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $5,767.04 | 2025 | |
| Madrigal Pharmaceuticals | $779.43 | 2024-2025 | Rezdiffra, Resmetirom |
| Gilead Sciences, INC. | $141.86 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $106.77 | 2023 | Envarsus |
| Orphalan INC | $92.19 | 2024 | Cuvrior |
| Astrazeneca Pharmaceuticals LP | $88.69 | 2021 | |
| Abbvie INC. | $61.82 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $27.92 | 2024 | Utaswako Afp-L3 |
| Alexion Pharmaceuticals, INC. | $17.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.